Ocular Therapeutix, Inc.
OCUL
$7.45
-$0.49-6.17%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 10.74% | -6.18% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 10.74% | -6.18% | |||
| Cost of Revenue | 9.33% | 27.17% | |||
| Gross Profit | -8.40% | -66.54% | |||
| SG&A Expenses | 11.53% | -23.11% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.15% | 2.32% | |||
| Operating Income | -9.95% | -5.52% | |||
| Income Before Tax | -32.60% | 16.64% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -32.60% | 16.64% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -32.60% | 16.64% | |||
| EBIT | -9.95% | -5.52% | |||
| EBITDA | -10.18% | -5.64% | |||
| EPS Basic | -31.81% | 17.23% | |||
| Normalized Basic EPS | -31.77% | 17.21% | |||
| EPS Diluted | -30.91% | 16.67% | |||
| Normalized Diluted EPS | -31.77% | 17.21% | |||
| Average Basic Shares Outstanding | 0.61% | 0.70% | |||
| Average Diluted Shares Outstanding | 0.61% | 0.70% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
